U.S. Markets closed


Hamburg - Hamburg Delayed Price. Currency in EUR
Add to watchlist
53.30-0.15 (-0.28%)
At close: 8:09AM CEST
Interactive chart
Previous Close53.45
Bid0.00 x
Ask0.00 x
Day's Range53.30 - 53.30
52 Week Range51.70 - 68.03
Avg. Volume0
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters4 days ago

    Hikma cuts revenue forecast on generic Advair delay; shares sink

    Hikma Pharmaceuticals Plc lowered its full-year revenue forecast on Friday to reflect a delay in the launch of its generic asthma drug amid pricing pressures in the United States, sending its shares down to a three-year low. Earlier this month, the drugmaker said U.S. regulators decided not to approve its generic version of GlaxoSmithKline Plc's blockbuster lung drug Advair, citing "major" issues with the application. The company, which makes and markets branded and non-branded generic and injectable drugs, now expects full-year revenue to be in the range of $2 billion-$2.1 billion at constant currency, down from its earlier forecast of $2.2 billion.

  • Investopedia5 days ago

    Evaluating Amazon's Chances in the Pharma Industry

    Morgan Stanley has a couple of pointers for Amazon's entry into the pharma market.

  • PR Newswire5 days ago

    Express Scripts Subsidiary to Join Walgreens Boots Alliance Development Group Purchasing Organization

    ST. LOUIS, May 18, 2017 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX), through a wholly owned subsidiary, Innovative Product Alignment, LLC, today announced it will participate in Walgreens ...